Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Buy
29,075
+20,699
+247% +$7.09M 0.31% 52
2026
Q1
$2.95M Buy
8,376
+5,273
+170% +$1.88M 0.1% 390
2025
Q4
$1.02M Sell
3,103
-11,447
-79% -$3.63M 0.03% 691
2025
Q3
$4.11M Sell
14,550
-12,022
-45% -$3.49M 0.12% 322
2025
Q2
$7.42M Buy
26,572
+12,318
+86% +$3.49M 0.21% 173
2025
Q1
$4.44M Sell
14,254
-23,178
-62% -$6.84M 0.15% 258
2024
Q4
$9.76M Buy
+37,432
New +$11.1M 0.42% 14
2024
Q3
Sell
-2,733
Closed -$854K 828
2024
Q2
$854K Sell
2,733
-9,701
-78% -$2.85M 0.04% 558
2024
Q1
$3.54M Buy
12,434
+8,524
+218% +$2.49M 0.18% 195
2023
Q4
$1.13M Sell
3,910
-2,354
-38% -$641K 0.08% 405
2023
Q3
$1.68M Buy
6,264
+873
+16% +$218K 0.13% 244
2023
Q2
$1.2M Buy
5,391
+3,852
+250% +$894K 0.11% 317
2023
Q1
$372K Sell
1,539
-2,549
-62% -$626K 0.04% 444
2022
Q4
$1.07M Sell
4,088
-2,952
-42% -$791K 0.12% 252
2022
Q3
$1.59M Buy
7,040
+5,088
+261% +$1.23M 0.12% 225
2022
Q2
$475K Buy
+1,952
New +$478K 0.04% 412
2021
Q4
Sell
-40,427
Closed -$8.6M 476
2021
Q3
$8.6M Buy
+40,427
New +$9.3M 0.53% 47
2021
Q1
Sell
-28,039
Closed -$6.45M 375
2020
Q4
$6.45M Sell
28,039
-57,214
-67% -$13.2M 0.32% 110
2020
Q3
$21.7M Buy
85,253
+63,433
+291% +$15.7M 1.4% 8
2020
Q2
$5.15M Buy
21,820
+13,908
+176% +$3.17M 0.27% 113
2020
Q1
$1.6M Buy
7,912
+4,422
+127% +$966K 0.15% 158
2019
Q4
$841K Buy
3,490
+2,230
+177% +$492K 0.04% 246
2019
Q3
$244K Sell
1,260
-70,977
-98% -$13.6M 0.02% 244
2019
Q2
$13.3M Sell
72,237
-1,376
-2% -$246K 1.5% 16
2019
Q1
$14M Buy
+73,613
New +$14.1M 2.05% 5
2018
Q4
Sell
-1,043
Closed -$216K 220
2018
Q3
$216K Buy
+1,043
New +$206K 0.04% 245
2015
Q2
Sell
-6,950
Closed -$1.11M 105
2015
Q1
$1.11M Buy
6,950
+4,433
+176% +$698K 1.45% 22
2014
Q4
$401K Sell
2,517
-6,427
-72% -$1M 0.92% 38
2014
Q3
$1.26M Sell
8,944
-2,107
-19% -$275K 1.1% 27
2014
Q2
$1.31M Buy
+11,051
New +$1.28M 0.83% 32

Other funds holding AMGN

Edgestream Partners's AMGN Position: Q2 2026 in Review

Edgestream Partners increased its Amgen (AMGN) stake by 247% in Q2 2026, buying an estimated $7.09M and bringing the position to 29,075 shares worth $10.5M. The position accounts for 0.31% of the portfolio, ranked #52.

Edgestream Partners first reported a position in AMGN in Q2 2014 and has held it in 30 quarters since. The position peaked at $21.7M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Edgestream Partners held 29,075 shares of Amgen worth $10.5M as of Q2 2026.
  • Edgestream Partners bought 20,699 Amgen shares in Q2 2026, an estimated $7.09M.
  • Amgen made up 0.31% of Edgestream Partners's portfolio in Q2 2026, its #52 holding.
  • Edgestream Partners first reported a position in Amgen in Q2 2014 and has held it in 30 quarters since.
  • Edgestream Partners's Amgen position peaked at $21.7M in Q3 2020.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.